These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

857 related articles for article (PubMed ID: 17169498)

  • 1. A novel interpretation of immune redundancy and duality in reperfusion injury with important implications for intervention in ischaemic disease.
    Thrane AS; Skehan JD; Thrane PS
    Med Hypotheses; 2007; 68(6):1363-70. PubMed ID: 17169498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury.
    Heller T; Hennecke M; Baumann U; Gessner JE; zu Vilsendorf AM; Baensch M; Boulay F; Kola A; Klos A; Bautsch W; Köhl J
    J Immunol; 1999 Jul; 163(2):985-94. PubMed ID: 10395696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of C5a in inflammatory responses.
    Guo RF; Ward PA
    Annu Rev Immunol; 2005; 23():821-52. PubMed ID: 15771587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complement activation and inflammation].
    Abe M
    Rinsho Byori; 2006 Jul; 54(7):744-56. PubMed ID: 16913666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice.
    Kumar V; Ali SR; Konrad S; Zwirner J; Verbeek JS; Schmidt RE; Gessner JE
    J Clin Invest; 2006 Feb; 116(2):512-20. PubMed ID: 16453025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation.
    De Vries B; Matthijsen RA; Wolfs TG; Van Bijnen AA; Heeringa P; Buurman WA
    Transplantation; 2003 Feb; 75(3):375-82. PubMed ID: 12589162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent functions of CD4+ T lymphocytes in acute liver inflammation and injury after ischemia-reperfusion.
    Caldwell CC; Okaya T; Martignoni A; Husted T; Schuster R; Lentsch AB
    Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G969-76. PubMed ID: 16002566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural antibody mediated innate autoimmune response.
    Zhang M; Carroll MC
    Mol Immunol; 2007 Jan; 44(1-3):103-10. PubMed ID: 16876247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle.
    Pemberton M; Anderson G; Vĕtvicka V; Justus DE; Ross GD
    J Immunol; 1993 Jun; 150(11):5104-13. PubMed ID: 8496606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in rats.
    Arumugam TV; Woodruff TM; Stocks SZ; Proctor LM; Pollitt S; Shiels IA; Reid RC; Fairlie DP; Taylor SM
    J Hepatol; 2004 Jun; 40(6):934-41. PubMed ID: 15158333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement mediators in ischemia-reperfusion injury.
    Arumugam TV; Magnus T; Woodruff TM; Proctor LM; Shiels IA; Taylor SM
    Clin Chim Acta; 2006 Dec; 374(1-2):33-45. PubMed ID: 16872589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice.
    Moulton RA; Mashruwala MA; Smith AK; Lindsey DR; Wetsel RA; Haviland DL; Hunter RL; Jagannath C
    J Leukoc Biol; 2007 Oct; 82(4):956-67. PubMed ID: 17675563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of anaphylatoxins, their diversity and novel roles in innate immunity: insights from the study of fish complement.
    Sunyer JO; Boshra H; Li J
    Vet Immunol Immunopathol; 2005 Oct; 108(1-2):77-89. PubMed ID: 16112742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
    Oppermann M; Götze O
    Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for the C3a anaphylatoxin receptor in the effector phase of asthma.
    Humbles AA; Lu B; Nilsson CA; Lilly C; Israel E; Fujiwara Y; Gerard NP; Gerard C
    Nature; 2000 Aug; 406(6799):998-1001. PubMed ID: 10984054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C5a and Fcgamma receptors: a mutual admiration society.
    Atkinson JP
    J Clin Invest; 2006 Feb; 116(2):304-6. PubMed ID: 16453017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate autoimmunity.
    Carroll MC; Holers VM
    Adv Immunol; 2005; 86():137-57. PubMed ID: 15705421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both FcgammaRIV and FcgammaRIII are essential receptors mediating type II and type III autoimmune responses via FcRgamma-LAT-dependent generation of C5a.
    Syed SN; Konrad S; Wiege K; Nieswandt B; Nimmerjahn F; Schmidt RE; Gessner JE
    Eur J Immunol; 2009 Dec; 39(12):3343-56. PubMed ID: 19795417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopathogenesis of ischemia/reperfusion-associated tissue damage.
    Ioannou A; Dalle Lucca J; Tsokos GC
    Clin Immunol; 2011 Oct; 141(1):3-14. PubMed ID: 21839685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of C5a in the innate immune response after experimental blunt chest trauma.
    Flierl MA; Perl M; Rittirsch D; Bartl C; Schreiber H; Fleig V; Schlaf G; Liener U; Brueckner UB; Gebhard F; Huber-Lang MS
    Shock; 2008 Jan; 29(1):25-31. PubMed ID: 17621257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.